🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
The purpose of this prospective study is to perform Nerve conduction test, ...
Status
Unknown
Location
Himalayan Hospital(Cancer Research Institute), Himalayan Institute of Medical Sciences
Start Date
2022-11-23
Trial ID
NCT06491082
Treatments Being Tested
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
This is a prospective, multicenter, randomized, uncontrolled Phase II study...
Status
Recruiting
Location
Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University
Start Date
2024-09-24
Trial ID
NCT06775275
Treatments Being Tested
The primary objective of this study is to evaluate the objective response r...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-10
Trial ID
NCT07351565
Treatments Being Tested
Previous studies have suggested that immunotherapy combined with chemothera...
Status
Unknown
Location
Hunan Cancer hospital
Start Date
2022-11-25
Trial ID
NCT05430906
Treatments Being Tested
This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00312728
Treatments Being Tested
A Single-Center Retrospective Study About Efficacy and Safety of Eribulin-B...
Status
Unknown
Location
Fujian Cancer Hospital
Start Date
2023-02-01
Trial ID
NCT05953909
Treatments Being Tested
This phase III trial compares the effectiveness of pembrolizumab and sacitu...
Status
Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2025-12-02
Trial ID
NCT06524544